Field safety notices: IMMY
Group or brand name: several entities registered in EUDAMED may be concerned. The exact entity is named in each notice, at the source.
5 authority publications by 2 authorities, from 28 Nov 2019 to 4 Mar 2025.
Latest notice: 4 Mar 2025, ANSM, Réactif Candida Immunodiffusion (ID) Antigen
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by IMMY or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
4 distinct corrective actions.
- Réactif Candida Immunodiffusion (ID) Antigen
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Ensayo de Flujo Lateral de Antígeno de Cryptococcus (CrAg LFA), referencia: CR2003
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026
- Ensayo de Flujo Lateral (LFA) del sona Aspergillus GM, referencia AF2003
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026
Corrective action: 2 publications by AEMPS, ANSM, from 28 Nov 2019 to 2 Dec 2019
- Réactif Histoplasma Immunodiffusion (ID) Antigen
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Antígeno de Inmunodifusion (ID) de Histoplasma, referencia H50110
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026